Ontology highlight
ABSTRACT: Background
The aim of this study was to investigate the clinical features, immunohistochemistry (IHC), compound mutation, and prognosis of patients with non-small cell lung cancer (NSCLC) harboring exon 19 deletion-insertion mutations.Methods
This retrospective analysis included 4,666 NSCLC patients harboring epidermal growth factor receptor (EGFR) mutations in a multi-center study from January 2017 to December 2020, and 69 patients with EGFR exon 19 deletion-insertions were taken to account. Next-generation sequencing (NGS) was used to detect the subtype of EGFR exon 19 deletion-insertions. These mutations were correlated with clinical features, immunophenotype and molecular characteristics of tumors and outcomes of patients.Results
Sixty-nine patients with EGFR ex
SUBMITTER: Chen Y
PROVIDER: S-EPMC8902088 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature